Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Expert Opinion on Therapeutic Targets|November 15, 2014
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatmentAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Metabolism|June 10, 2010
Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's diseaseStergios A Polyzos, Athanasios D Anastasilakis, Ioannis Litsas, et al.
Clinical Endocrinology|April 28, 2011
Apelin levels in normal pregnancyAnargyros Kourtis, Athina Gkiomisi, Maria Mouzaki, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2021
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTSAthanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2014
Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene)Stergios A Polyzos, Panagiotis N Singhellakis, Dorit Naot, et al.
Calcified Tissue International|January 2, 2021
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 30, 2018
Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy ControlsAthanasios D Anastasilakis, Dimitrios Koulaxis, Jagriti Upadhyay, et al.
Reviews in Endocrine & Metabolic Disorders|August 20, 2024
Primary hyperparathyroidism: from guidelines to outpatient clinicAndrea Palermo, Gaia Tabacco, Polyzois Makras, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2018
Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Maria Pikilidou, et al.
Clinical Endocrinology|June 9, 2012
The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Sideris Delaroudis, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Expert Opinion on Therapeutic Targets|November 15, 2014
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatmentAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Metabolism|June 10, 2010
Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's diseaseStergios A Polyzos, Athanasios D Anastasilakis, Ioannis Litsas, et al.
Clinical Endocrinology|April 28, 2011
Apelin levels in normal pregnancyAnargyros Kourtis, Athina Gkiomisi, Maria Mouzaki, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2021
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTSAthanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2014
Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene)Stergios A Polyzos, Panagiotis N Singhellakis, Dorit Naot, et al.
Calcified Tissue International|January 2, 2021
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 30, 2018
Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy ControlsAthanasios D Anastasilakis, Dimitrios Koulaxis, Jagriti Upadhyay, et al.
Reviews in Endocrine & Metabolic Disorders|August 20, 2024
Primary hyperparathyroidism: from guidelines to outpatient clinicAndrea Palermo, Gaia Tabacco, Polyzois Makras, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2018
Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Maria Pikilidou, et al.
Clinical Endocrinology|June 9, 2012
The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Sideris Delaroudis, et al.
Pageof 16